← Leaderboards
Scott Michael Norton
Baebies, Inc.
$1,935,099
Attributed
$1,935,099
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2016–17$2M$1.5M$1M$500K$0
'16
'17
Funding mix
By agency
NIH$1,935,099 · 2
By mechanism
R44$1,935,099 · 2
Top collaborators
No co-investigators on record.
Most similar at Baebies, Inc.
Same institution · by research overlap
- Rajendra Singh$3,079,363
- Ramakrishna Sista$696,600
Others in their field
Top investigators on “Reagent”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Lawrence Corey · Fred Hutchinson Cancer Center$239,426,049
- Timothy Stedman · American Type Culture Collection$135,545,770
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,090,673
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$105,181,167
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,846,879
Research focus
ReagentUnited StatesInstrumentPilot ProjectsSensitivity And SpecificityTechnologyInfantDevicesNeonatal ScreeningNewborn InfantSamplingScreeningBaseSpottingsFundingFutureBiochemicalDesignLaboratoriesMicrofluidicsBirthDigitalBloodUniversities
Grant awards (3)
Point-of-birth newborn screening for MCAD/VLCAD and galactosemia to eliminate deadly delays for time critical conditions$917,787
R44 · FY2017 · HD · contact PI
Rapid, Near Patient Nucleic Acid Testing for Congenital Cytomegalovirus (CMV) Infection$763,182
R44 · FY2017 · DC · contact PI
Point-of-birth newborn screening for MCAD/VLCAD and galactosemia to eliminate deadly delays for time critical conditions$254,130
R44 · FY2016 · HD · contact PI